Diabetes Spend Is Growing 4 Slower Than Non-Diabetic Costs: What the Data Shows The financial data shows an unmistakable shift: Annual spend for diabetics increased just 11% from 2021-2024 , while spend for non-diabetics jumped 15% Average monthly medical spend for diabetics decreased slightly (0.5%) , while non-diabetic medical spend surged 17% Prescription growth for diabetics (34%) stayed well below the 57% spike for non-diabetics For the first time, diabetic spend is flattening faster than non-diabetic spendcompletely reversing the previous pattern where diabetes costs outpaced everything else by 2x
All prescriptions are at the discretion of a medical provider
All non-profit organizations must use a portion of donations to support administrative and fundraising functions, like the salaries of our employees who collect and distribute funds, the investment in technology that enables us to provide better support to our clients, and campaign mailers to generate contributions
They can often provide documentation to help with HSA/FSA eligibility
Who Each Peptide Fits Best Choose Sermorelin if you want: A gentler, more physiologic GH pattern Better sleep and gradual anti-aging effects as primary goals A peptide you can run continuously for longer periods (3+ months) without cycling Your first experience with growth-hormone-supporting therapy Slower, sustainable improvements without pronounced acute effects Choose CJC-1295/Ipamorelin if you want: Faster, more noticeable changes within the first 2-3 weeks Stronger body composition effects, particularly when paired with resistance training Better recovery from intense training or post-injury rehabilitation To pair with other peptides (BPC-157, TB-500, or Tesamorelin) for compound effects A protocol that can be cycled strategically to maintain effectiveness over time Stacking with Other Therapies Both peptides combine well with other Solas treatments
/assets/docs/446094.jpg)
